Central lab for protocol entitled a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, effects on the mechanisms of contraceptive efficacy and safety of…
Ended Awarded Last action
- Contract number
- HHSN27500004
- Awardee
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $446,266
Award facts
- Contract value 100% obligated
- $446,266.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$6,748 | |
| Change Order | $0 | |
| Funding Only Action | $130,960 | |
| Change Order | $14,125 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $307,929 |
About this award
Oregon Health & Science University was awarded a delivery order against an indefinite-delivery/indefinite-quantity contract vehicle by the National Institutes of Health National Institute of Child Health and Human Development. The $446,266.45 contract calls for Oregon Health & Science University to serve as the central laboratory for a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, effects on the mechanisms of contraceptive efficacy and safety of daily oral low dose ulipristal acetate. No set-aside designation was used for this award. Performance will take place in Portland, Oregon through March 2023 to support the National Institutes of Health's research efforts.
Description
Central lab for protocol entitled a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, effects on the mechanisms of contraceptive efficacy and safety of daily oral low dose ulipristal acetate
Quick answers
Who was awarded contract HHSN27500004?
HHSN27500004 was awarded to Oregon Health & Science University by National Institute of Child Health and Human Development (National Institutes of Health) on November 21, 2013.
How much is contract HHSN27500004 worth?
The government has obligated $446,266 on HHSN27500004.
Is contract HHSN27500004 an order under another contract?
Yes. HHSN27500004 is a delivery order under HHSN275201300008I, an indefinite delivery contract.
Was contract HHSN27500004 competed?
The extent of competition for HHSN27500004 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award